Cavalier Investments’s DexCom DXCM Stock Holding History

Cavalier Investments’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,968	Closed	-$821K	–	101
2020 Q3	$821K	Sell	7,968 -4,644	-37%	-$485K	0.56%	55
2020 Q2	$1.28M	Buy	12,612 +5,012	+66%	+$448K	0.74%	39
2020 Q1	$512K	Sell	7,600 -6,400	-46%	-$398K	0.3%	65
2019 Q4	$766K	Hold	14,000	–	–	0.33%	65
2019 Q3	$522K	Hold	14,000	–	–	0.23%	80
2019 Q2	$524K	Hold	14,000	–	–	0.22%	78
2019 Q1	$417K	Hold	14,000	–	–	0.17%	101
2018 Q4	$419K	Buy	+14,000	New	+$444K	0.14%	112

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cavalier Investments's DXCM Position: Q4 2020 in Review

Cavalier Investments sold out of DexCom (DXCM) in Q4 2020, closing a stake of 7,968 shares — an estimated $821K sold.

Cavalier Investments first reported a position in DXCM in Q4 2018 and held it in 8 quarters. The position peaked at $1.28M in Q2 2020. 734 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

Cavalier Investments reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
Cavalier Investments sold 7,968 DexCom shares in Q4 2020, an estimated $821K.
Cavalier Investments first reported a position in DexCom in Q4 2018 and held it in 8 quarters.
Cavalier Investments's DexCom position peaked at $1.28M in Q2 2020.
734 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Cavalier Investments's 13F filing for Q4 2020, filed 12 Feb 2021.